Research programmes

The development of safe and effective vaccines against infectious diseases such as SARS-CoV2, Zika, malaria, Ebola and the emerging zoonoses is a major goal in global public health. Also, cancer clearly remains one of the leading causes of disease and mortality worldwide. Recent advances in immunotherapy and cell therapy established them as potential new modalities ...

In the last two decades our programme P3-0298 is based on activities and achievements in basic, laboratory and clinical research in the field of chronic metabolic disorders such as osteoporosis and bone metabolism, polycystic ovary syndrome (PCOS), diabetes type 2 and insulin resistance as a common component of the last two disorders. During 20 years we published mo...

The main focus of the Programme Group “Pharmaceutical technology: from drug delivery systems to therapeutic outcomes of medicines in children and elderly” is the delivery of the active pharmaceutical ingredients (API) to the targeted site in the body and the optimization of drug therapy in different groups of patients. The Group's research programme is d...

Cancer, neurodegenerative and immune diseases represent a great health and social burden for our society. Due to prolongation of life expectancy the burden of these predominantly  age-related diseases is anticipated to be even greater in the future. To avoid the collapse of the health care system, new, more effective therapy strategies are urgently needed. Our ...

Our research program P3-0314 encompasses rheumatologists, pulmonologists, neurologists, gastroenterologists, biochemists, pharmacists, molecular/cell biologists, biostaticians/bioinformaticians, laboratory experts, economists and patients groups. Activities are predominantly geared towards optimization of therapy/drug repurposing, elucidation of disease mechanism fo...

The development of safe and effective vaccines against infectious diseases such as SARS-CoV2, Zika, malaria, Ebola and the emerging zoonoses is a major goal in global public health. Also, cancer clearly remains one of the leading causes of disease and mortality worldwide. Recent advances in immunotherapy and cell therapy established them as potential new modalities ...

The long-term goal of the research programme is the discovery of new bioactive small molecules with a potential for development into drugs for use in important therapeutic areas through combined medicinal chemistry approaches. In the next period, the research programme will focus on the discovery and rational design, synthesis and biological evaluation of molecules ...

Cancer, neurodegenerative and immune diseases represent a great health and social burden for our society. Due to prolongation of life expectancy the burden of these predominantly  age-related diseases is anticipated to be even greater in the future. To avoid the collapse of the health care system, new, more effective therapy strategies are urgently needed. Our ...

Our programme is based on activities and achievements in the last two decades in the field of chronic metabolic disorders such as osteoporosis and bone metabolism, polycystic ovary syndrome (PCOS), diabetes type 2 (and to a lesser degree type 1) and insulin resistance as a common component of the last two disorders. The majority of our activities will be further res...

 The long-term goal of the research programme is discovery of new bioactive small molecules with a potential for development to drugs in important therapeutic areas through combined medicinal chemistry approaches. In the next period the research programme will focus on discovery and rational design of bioactive molecules exerting their action on validated drug ...